Kenneth Chang
KK Women's and Children's Hospital(SG)Duke-NUS Medical School(SG)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, DNA Repair Mechanisms, Glioma Diagnosis and Treatment, RNA Interference and Gene Delivery, Epigenetics and DNA Methylation
Most-Cited Works
- → Reveal-More: Amplifying Human Effort in Quality Assurance Testing Using Automated Exploration(2019)26 cited
- → In Vivo Needle-Based Confocal Laser Endomicroscopy (nCLE) Study in the Pancreas With Endosonography of Cystic Tumors (INSPECT) : Interim Results From an International Prospective Multicentric Study(2011)2 cited
- → Figure S5 from Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma(2023)
- → Figure S6 from Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma(2023)
- → Data from Transcriptional Silencing of <i>ALDH2</i> Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia(2023)
- → Supplementary Table S1 from Transcriptional Silencing of <i>ALDH2</i> Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia(2023)
- → Supplementary Table S2 from Transcriptional Silencing of <i>ALDH2</i> Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia(2023)
- → Figure S3 from Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma(2023)